Valiant Laboratories Limited (NSE:VALIANTLAB)

Market Cap	5.08B
Revenue (ttm)	1.33B
Net Income (ttm)	-22.01M
Shares Out	43.45M
EPS (ttm)	-0.51
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	5,417
Average Volume	44,131
Open	115.94
Previous Close	115.51
Day's Range	114.01 - 115.94
52-Week Range	75.20 - 157.49
Beta	n/a
RSI	57.02
Earnings Date	Aug 7, 2025

About Valiant Laboratories

Valiant Laboratories Limited operates as an active pharmaceutical ingredient/bulk drug manufacturing company in India and internationally. The company manufactures paracetamol in various grades, such as Indian/British/European/the United States pharmacopoeias for the treatment of headaches, muscle aches, arthritis, back aches, toothaches, cold, and fever. It also offers specialty chemicals. The company was formerly known as Bharat Chemicals and changed its name to Valiant Laboratories Limited in August 2021. The company was founded in 1980 and ...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1980
• Employees: 77
• Stock Exchange: National Stock Exchange of India
• Ticker Symbol: VALIANTLAB